Hangzhou Alltest Biotech Co. Ltd. A
Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; flu… Read more
Market Cap & Net Worth: Hangzhou Alltest Biotech Co. Ltd. A (688606)
Hangzhou Alltest Biotech Co. Ltd. A (SHG:688606) has a market capitalization of $681.81 Million (CN¥5.00 Billion) as of March 29, 2026. Listed on the SHG stock exchange, this China-based company holds position #13838 globally and #3562 in its home market, demonstrating a -4.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hangzhou Alltest Biotech Co. Ltd. A's stock price CN¥63.10 by its total outstanding shares 79280855 (79.28 Million).
Hangzhou Alltest Biotech Co. Ltd. A Market Cap History: 2021 to 2026
Hangzhou Alltest Biotech Co. Ltd. A's market capitalization history from 2021 to 2026. Data shows change from $708.87 Million to $681.81 Million (-7.16% CAGR).
Hangzhou Alltest Biotech Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hangzhou Alltest Biotech Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.79x
Hangzhou Alltest Biotech Co. Ltd. A's market cap is 0.79 times its annual revenue
169.85x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
2.26x
Hangzhou Alltest Biotech Co. Ltd. A's market cap is 2.26 times its annual earnings
822.69x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $708.87 Million | $1.87 Billion | $765.69 Million | 0.38x | 0.93x |
| 2022 | $619.90 Million | $3.39 Billion | $1.18 Billion | 0.18x | 0.52x |
| 2023 | $703.61 Million | $754.70 Million | $180.58 Million | 0.93x | 3.90x |
| 2024 | $683.97 Million | $866.58 Million | $302.47 Million | 0.79x | 2.26x |
Competitor Companies of 688606 by Market Capitalization
Companies near Hangzhou Alltest Biotech Co. Ltd. A in the global market cap rankings as of March 29, 2026.
Key companies related to Hangzhou Alltest Biotech Co. Ltd. A by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #103 globally with a market cap of $159.77 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #256 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #365 globally with a market cap of $58.71 Billion USD ( €57.20 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #483 globally with a market cap of $43.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #103 | Intuitive Surgical Inc | NASDAQ:ISRG | $159.77 Billion | $452.66 |
| #256 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #365 | EssilorLuxottica S. A. | PA:EL | $58.71 Billion | €194.80 |
| #483 | Becton Dickinson and Company | NYSE:BDX | $43.88 Billion | $154.51 |
Hangzhou Alltest Biotech Co. Ltd. A Historical Marketcap From 2021 to 2026
Between 2021 and today, Hangzhou Alltest Biotech Co. Ltd. A's market cap moved from $708.87 Million to $ 681.81 Million, with a yearly change of -7.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥681.81 Million | -1.24% |
| 2025 | CN¥690.35 Million | +0.93% |
| 2024 | CN¥683.97 Million | -2.79% |
| 2023 | CN¥703.61 Million | +13.50% |
| 2022 | CN¥619.90 Million | -12.55% |
| 2021 | CN¥708.87 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 29th, 2026 the market cap of Hangzhou Alltest Biotech Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $681.81 Million USD |
| MoneyControl | $681.81 Million USD |
| MarketWatch | $681.81 Million USD |
| marketcap.company | $681.81 Million USD |
| Reuters | $681.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.